Company intelligence / Profile preview

LigniLabs GmbH

Wiesbaden, Hesse, Germanylignilabs.de ↗

Ownership: Private
Development stage: Preclinical

Overview

The company’s lead product, ESCApe, has demonstrated good efficacy against the previously incurable grapevine disease ESCA in both laboratory and field trials. It uses a novel lignin-based microcarrier system to deliver active ingredients directly to pathogens. The product is currently undergoing regulatory approval. The technology has also won several innovation awards. No clinical results are available as this relates to crop protection rather than human clinical trials.

Therapeutic areas: Other
Modalities: Microcarrier-based encapsulation (lignin microcarriers for active ingredient delivery)
Industry: Agriculture & AgTech

Drug pipeline

1 asset

ESCApe

Pre-clinical

Indications: ESCA disease in grapevines

Partnerships

Institute for Biotechnology and Drug Research at the University of Mainz (IBWF)Dienstleistungszentrum Ländlicher Raum (DLR)

Beyond the preview

Go deeper on LigniLabs GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LigniLabs GmbH.

Explore the full profile